Seppo Makinen

Oiva Health is the leading Digital Care provider in the Nordics. We offer a comprehensive Digital Platform for integrated health and care services to digitalize primary healthcare, social care, hospital healthcare and long-term care services. We are the only Digital Health platform on the market that truly integrates healthcare and social care services. Our platform makes digital healthcare available also for those patients whose ability to function has already significantly weakened. Currently Oiva Health platform is available in Finland, Denmark, Sweden, Norway and Iceland.

Evondos is amongst the first companies to bring robotization and AI into the home care services. We offer a robotized solution for safe medicine distribution in professional home care. With our service, home care clients are supported to take medication as prescribed: the right medication in a correct dosage at the right time. Our service not only increases medical adherence and patient safety but also offers possibilities in process optimization. The service is used in ca. 200 municipalities around the Nordics. More than ten million dosages have been dispensed to the homecare clients across Nordic markets. Evondos headquarters and production facilities are located in Salo, Finland and the company currently employs ca. 130 employees working in Finland, Sweden, Norway and Denmark.

We are shaping the future of Personalised Medicine, by bringing the wealth of genetic information into clinical practice. We work to apply the most advanced genomic knowledge at the service of health.

Neurotar’s mission is to advance brain research in live animals as a more translational alternative to in vitro and ex vivo research. To this end, we provide in vivo two-photon imaging of the mouse brain as a service for global pharmaceutical and biotech companies working in the CNS area. Key focus areas are trans-BBB PK of large molecules, Alzheimer's disease, and stroke. In vivo two-photon imaging allows studying the brain longitudinally with subcellular resolution. In our second line of business, we commercialize innovative research tools (Mobile HomeCage line of products) that facilitate basic research in live and non-anesthetized mice. Mobile HomeCage products eliminate the biases associated with the use of anesthetics and allow combining high precision techniques (in vivo two-photon imaging, in vivo electrophysiology, optogenetics) with behavioral studies. The Mobile HomeCage is used by 130+ academic and industrial labs worldwide, primarily in North America and Central Europe.

Critical Ventures is a VC that invests in game-changing companies with the power to transform the way the world uses technology, in the areas of IoT, Automatization and Digitalization, Cybersecurity, AI/ML/Descentralised tech, UxD/Interfaces, Mobility and Medical Software. We know that building disruptive tech companies takes more than just capital. As tech entrepreneurs ourselves, we work side by side with the companies we invest in, backing them with funding, time and real expertise. We believe that technology is nothing without the passion of talented people bringing it to life. That’s why we’re dedicated to working with entrepreneurs and startups who share our culture and values. In return, we help to nurture the companies we invest in and grow them organically, in their own time – avoiding round after round of funding. For us, investing isn’t just our business. It’s the chance to make a difference and create something big. From founders for founders

Developing life science ideas into global growth stories. We partner with founder teams. SLS Ventures senior executives look back on 200 years experience in building companies. We contribute time and funds to help you build your prototype, get your product to market, and secure additional early funding. Our clients are start-up or university teams with life science focus located Western Europe. Filed or granted IP that can be reviewed under NDA and prove technology feasibility and first pre-seed investment such as EXIST or angel investor round completed.

Oiva Health is the leading Digital Care provider in the Nordics. We offer a comprehensive Digital Platform for integrated health and care services to digitalize primary healthcare, social care, hospital healthcare and long-term care services. We are the only Digital Health platform on the market that truly integrates healthcare and social care services. Our platform makes digital healthcare available also for those patients whose ability to function has already significantly weakened. Currently Oiva Health platform is available in Finland, Denmark, Sweden, Norway and Iceland.

PATHENA is a Venture Capital firm boosting the success of European Information Technology and Digital Health companies. The team is composed by an experienced group, working together for more than 15 years. With strong international track-record in Entrepreneurship and Venture Capital in Technology and Digital Health, the in-house expertise is complemented by world-class industry experts. Currently with €70M Assets Under Management, PATHENA’s portfolio is composed by 13 active companies operating, among others, in the fields of respiratory diseases, patient’s digital condition recognition, machine vision, and robotics and software. Previous successful Exits include trade sales to strategic players such as Microsoft, Wipro, and Smith Micro. Portfolio overview available @ http://www.pathena.com/portfolio